A comprehensive view of Approved Drugs/Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Morningstar assigns AstraZeneca with US$74 fair value estimate, indicating 12% upside, as it's developing several products with blockbuster potential; recently launched drugs Tagrisso, Imfinzi are well-positioned based on efficacy in hard-to-treat cancers

FDA approves Dutch biotech firm UniQure’s Hemgenix injectable to treat hemophilia B, making it the first gene therapy treatment for the disorder; Australian drugmaker CSL has license for the treatment and places list price at US$3.5M

US Senator Mike Lee introduces proposal to end FDA biosimilar switching studies, make all approved biosimilars interchangeable; FDA has granted interchangeable status to only four of 39 biosimilars it has approved

Alliance Defending Freedom files suit against FDA, HHS to overturn FDA's approval of Mifeprex mifepristone abortion pill; NY Times reports abortion by medication accounts for half of abortions in US

Japan approves domestically developed COVID-19 oral antiviral Xocova developed by Shionogi; company to seek US approval for the drug

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count